X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Coming soon: Clinical Trials Awareness Week, May 2-6

By Andrew Powaleny  |    April 28, 2016
Clinical trials are the most effective way to find new, innovative treatments for illnesses patients may face. But misconceptions and lack of awareness about this important research often keep...   Read More

Clinical Trials Q&A: Examining clinical trial design

By Jocelyn Ulrich  |    April 12, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    March 18, 2016
ICYMI: Policy solutions for innovative treatment: Last week at our 2016 Annual Meeting, our president and CEO Steve Ubl discussed his vision for the organization and outlined policy solutions for...   Read More

Clinical Trials Q&A: Income disparities

By Jocelyn Ulrich  |    March 14, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

ICYMI: American Society for Clinical Oncology statement on clinical pathways

By Kelsey Lang  |    January 18, 2016
Last week, the American Society for Clinical Oncology (ASCO) issued a policy statement calling for improvements in clinical pathway programs. The statement responds to the growing concern that...   Read More

New Video: Clinical trials serve as engine for local economic growth

By Priscilla VanderVeer  |    November 18, 2015
Without clinical trials, new medicines could not be approved and made available to the patients who need them. But beyond connecting patients to new treatments and potential cures for some of the...   Read More

BMJ clinical trial report misleading

By Jocelyn Ulrich  |    November 16, 2015
Biopharmaceutical companies are committed to enhancing the transparency of their research in a responsible manner. To demonstrate their commitment, in July 2013 PhRMA joined with the European...   Read More

Clinical Trials Q&A: Improving the recruitment process by listening to patients

By Jocelyn Ulrich  |    October 22, 2015
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today's challenges and opportunities. The Catalyst welcomes guest...   Read More

Clinical Trials Q&A : How does collaboration increase clinical trial awareness and access?

By Jocelyn Ulrich  |    October 20, 2015
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today's challenges and opportunities. The Catalyst welcomes guest...   Read More

Introducing clinical research participation to the everyday person

By Jocelyn Ulrich  |    October 15, 2015
Clinical trials involve many different people and institutions coming together to better understand disease, biology and the impact of potential medicines. Carefully conducted clinical trials are...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates